Biotechnology company
Issues related to Medicare and Medicaid coverage and reimbursement; 340B Drug Discount Program; drug pricing generally. HCR -Issues related to healthcare legislation, drug pricing generally including and the 340B Drug Discount Program; issues and policies relating to the FDA including biopharmaceutical development and biosimilars; general education about policies impacting pharmaceutical development, approval, reimbursement and pricing; issues related to health equity, diversity, and inclusion in clinical trials; issues related to public health preparedness and response.
MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
RIVENDELL GROUP LLP
1440 G Street, NW, Washington, DC, 20005, US
NICK KOLOVOS (LA and Counsel, Rep. Anna Eshoo) MATTHEW BERZOK (LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch) NICK KOLOVOS (LA and Counsel, Rep. Anna Eshoo) MATTHEW BERZOK (LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch)
LA and Counsel, Rep. Anna Eshoo LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch LA and Counsel, Rep. Anna Eshoo LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch